ANNEX 1 27 NOTE 20 — TABLE OF SUBSIDIARIES AND HOLDINGS On April 28, 2017, GenSight Biologics created its first subsidiary, States of America (State of Delaware). The Company doesn’t have GenSight Biologics Inc., registered and located in the United any other investment in a subsidiary. Capital Reserves % Book value of Loans and Guarantees Turnover Net Dividends (in Euros) and retained interest shares held advances and excluding income in booked earnings (in Euros) granted not security tax last year during the brought G Net yet refunded granted (in KEuros) year forward ross (in KEuros) GenSight 0.45 — 100% 0.45 0.45 888 — — (259) — Biologics Inc. The capital reserves and retained earnings have been translated into GenSight Biologics SA draws up consolidated accounts in which thousands of euros on the basis of year-end exchanges rates, while its subsidiary GensSight Biologics Inc. is fully consolidated. profits and losses have been translated at average rate. 256 – GENSIGHT BIOLOGICS – 2017 Registration Document